Skip to main content

Surgery Partners CS(SGRY-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low13.89
Day High14.67
Open:14.53
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
1 Mooning Stock with Impressive Fundamentals and 2 We Ignore
SGRY
StockStory
1 Cash-Producing Stock to Target This Week and 2 We Question
F
Zacks Investment Research
AUNA vs. SGRY: Which Hospital Stock Looks More Attractive Now?
AUNA vs. SGRY: Which Hospital Stock Looks More Attractive Now?
StockStory
3 Profitable Stocks We Find Risky
RSI
StockStory
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
NVST
GlobeNewswire
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
StockStory
1 High-Flying Stock for Long-Term Investors and 2 We Question
VPG
StockStory
3 Reasons to Avoid SGRY and 1 Stock to Buy Instead
SGRY
Tipranks
J.P. Morgan Keeps Their Hold Rating on Surgery Partners (SGRY)
StockStory
3 of Wall Street’s Favorite Stocks We Find Risky
VSCO
StockStory
3 Stocks Under $50 We Keep Off Our Radar
SGRY
GlobeNewswire
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
Tipranks
Analysts’ Top Healthcare Picks: Protara Therapeutics (TARA), Viridian Therapeutics (VRDN)
StockStory
3 Small-Cap Stocks with Warning Signs
NCNO
Newsfile
Fraud Investigation Opened: Levi & Korsinsky Investigates Surgery Partners, Inc. (SGRY) on Behalf of Shareholders
GlobeNewswire
Surgery Partners, Inc. to Present at Upcoming Investor Conference
StockStory
Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)
SGRY
Tipranks
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Surgery Partners (SGRY)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Surgery Partners (SGRY), Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY) and MannKind (MNKD)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surgery Partners (SGRY) and Keros Therapeutics (KROS)
Tipranks
RBC Capital Remains a Buy on Surgery Partners (SGRY)
StockStory
3 Russell 2000 Stocks with Questionable Fundamentals
CAKE
Tipranks
Surgery Partners Earnings Call Balances Growth And Strain
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Surgery Partners (SGRY) Receives a Hold from Barclays
Tipranks
Surgery Partners Announces Share Buyback and 2026 Outlook
StockStory
Surgery Partners’s (NASDAQ:SGRY) Q4 CY2025: Beats On Revenue But Stock Drops 18%
SGRY
GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program
GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
Motley Fool
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million
StockStory
1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky
CRI

Profile

Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.